Skip to main content
The Employer Market · LFP-04.04

The 16-to-50 Employer: Enough Scale for Real Plan Design, Not Enough for Self-Funded Confidence

By Syam Adusumilli · 9 min read
In a Hurry? Read the executive summary.

At 16 to 50 employees, the employer has arrived at a genuine choice. Both level funded and fully insured can work at this size. Neither is obviously wrong. The level funded value proposition, cost transparency, potential surplus return, plan design flexibility, and claims data access, is strongest here because the group is large enough for favorable stop loss economics and meaningful analytics, but not so large that the employer can comfortably self-fund without stop loss protection. The fully insured alternative is competitive precisely because community rating and carrier infrastructure provide real value for employers who want simplicity and rate stability. The decision should be structural, not price-driven, because the employer who chooses level funded only on a first-year cost comparison misunderstands what they are buying.

The KFF 2025 Employer Health Benefits Survey reports that 37 percent of covered workers in firms with 10 to 199 employees are enrolled in level funded plans, similar to the percentage in 2024. That figure represents a substantial portion of the small firm market and reflects how firmly level funded has embedded itself in this size range. It also reflects the segment’s structural fit: the 16-to-50 employer is level funded’s natural market.

What Scale Enables
#

Plan design flexibility emerges meaningfully at 16 or more lives. At smaller sizes, most TPAs offer standardized menus, typically two or three plan designs with set deductibles, coinsurance, and out-of-pocket limits. Custom plan design is not economically justified when the administrative cost of building and adjudicating a bespoke benefit structure is spread across 8 or 10 covered lives. At 16 or more lives, the math changes. The TPA can build a plan document reflecting the employer’s specific benefit preferences and recover the administrative cost across a viable member base.

Tiered benefit options become practical at this scale. Some employers offer two plan choices: either a high-deductible option with lower employee premiums and a traditional option with higher premiums, or a buy-up plan for employees who want richer coverage. Multiple plan options require administrative infrastructure the TPA can justify at this size. The employer who wants to give employees meaningful choice rather than a single take-it-or-leave-it plan can do so here in ways not operationally feasible at smaller sizes.

Pharmacy management becomes a lever at 25 or more covered lives. According to the KFF 2025 EHBS, the average single premium reached $9,325 in 2025, with pharmacy spend representing a growing share of that cost. An employer at this scale can negotiate PBM terms rather than accepting a standard contract. Step therapy requiring generic alternatives before brand drugs, prior authorization for specialty medications, and reference pricing for high-cost injectables are all manageable at this size. Pharmacy represents 20 to 30 percent of total health care spending for most small group plans. Meaningful pharmacy management produces measurable savings.

Wellness programs become feasible for the first time. The KFF 2025 EHBS shows that 35 percent of small firms (10 to 199 workers) provided workers the opportunity to complete a health risk assessment, and 22 percent offered biometric screenings, with the latter up 9 percentage points from 2024. With 20 to 50 covered lives, biometric screening and chronic disease identification produce enough data to act on. At smaller sizes, the population is too small for wellness programs to produce statistically meaningful results. At 25 or more, the employer can identify chronic disease prevalence, establish targeted disease management, and track outcomes over time.

HR capacity typically exists at this size for the first time. SHRM’s Human Capital Benchmarking Report suggests the industry average is approximately 1.7 HR professionals per 100 employees. Staffing firms tracking the threshold report that dedicated HR hiring becomes common as firms approach 50 workers. At 20 to 30 employees, the employer typically has at least a senior operations administrator managing benefits alongside other responsibilities. At 40 or more, a dedicated HR generalist is more common. HR capacity matters because level funded requires someone to engage with claims reports, renewal documentation, and stop loss coordination. The employer without anyone in this role will not realize the plan management benefits that justify the added complexity.

The Level Funded Case at This Size
#

The economic advantage of level funded is most pronounced in the 16-to-50 segment. Stop loss pricing is proportionally lower than at smaller group sizes because variance decreases as group size increases. A 25-person group with $500,000 in expected annual claims and actual claims of $400,000 could see $50,000 to $100,000 in surplus return, depending on contract terms and the corridor structure. That is a meaningful sum for a small employer. Over multiple favorable years, the compounding of surplus return changes the total cost calculus substantially relative to annual fully insured renewal.

The data advantage accumulates over time. At 25 or more covered lives, claims data becomes meaningful, not statistically complete but analytically useful,. The employer can identify utilization patterns: which services are used most, which providers are most expensive, which conditions are driving costs, and where pharmacy spend is concentrated. This data enables plan design adjustments at renewal. An employer who sees disproportionate emergency room utilization can implement a telemedicine benefit to redirect non-emergency care. An employer who identifies two members with the same expensive chronic condition can add a disease management program and a mail-order pharmacy requirement. These adjustments, implemented year over year, compound savings in a way that the single-year price comparison with fully insured does not capture.

ERISA preemption provides control that fully insured cannot match. The employer designs the plan through the plan document. They choose the network, the pharmacy benefit, the utilization management approach, and the wellness strategy. They are not subject to state benefit mandates on their self-funded plan (though the stop loss layer carries its own state regulation). They are not constrained to the carrier’s small group menu. For an employer who has specific coverage needs, specific employee demographics, or specific cost management priorities, the design control that level funded provides is genuinely valuable.

The Fully Insured Case at This Size
#

Fully insured remains competitive at this size and is the superior choice for specific employer profiles.

Simplicity has genuine value. Fully insured transfers the entirety of plan administration to the carrier. The employer pays premium and manages enrollment. No fiduciary responsibility for claims decisions, no stop loss renewal negotiation, no year-end reconciliation, no deficit risk. For an employer whose operations are the business and whose owner or administrator has no interest in engaging with plan management, that simplicity is not a concession. It is appropriate. The claim that every employer should want data and control overstates how much time and attention most small employers want to invest in benefits administration.

Rate stability matters for specific employer profiles. Fully insured community rating in the small group market spreads claims volatility across the pool. An employer with a covered member receiving $300,000 annually in specialty biologic medication for an autoimmune condition will be lasered in level funded: the stop loss carrier will exclude that individual from coverage at the specific deductible or price them separately at the full expected cost. In fully insured, community rating absorbs that cost without singling out the employer. The KFF 2025 EHBS reports an average single premium of $9,325, reflecting the pooled risk across all covered employees. That pooled structure benefits employers whose risk profile is above average, even as it charges healthy employers a cross-subsidy.

The carrier’s infrastructure investment is real. Large fully insured carriers invest in member engagement tools, chronic disease programs, digital care navigation, and provider network development at a scale most TPAs cannot match. The member experience in a major carrier’s fully insured plan (including 24/7 nurse lines, digital prior authorization, app interfaces, and responsive customer service) may be superior to what a small TPA’s level funded plan provides. For employers who compete for employees and view the benefit experience as part of the employment value proposition, the carrier’s infrastructure matters alongside the economics.

The Decision Framework
#

The employer at 16 to 50 lives should evaluate structural questions rather than leading with price.

Does the employer want to own claims data and use it for plan management? Level funded provides data that fully insured does not. But if the employer will not engage with claims reports, will not work with a broker to interpret utilization patterns, and will not make plan design adjustments at renewal, this advantage is wasted. The employer should assess honestly whether they have the capacity and inclination to act on data before choosing the product that requires it.

Does the employer have risk tolerance for renewal volatility? Level funded pricing reflects actual experience. A bad claims year produces a higher renewal. An employer who experiences 40 percent renewal increase in year two because one member had a serious cardiac event, then switches back to fully insured to escape the volatility, has not benefited from level funded. They have experienced the downside without accumulating the multi-year surplus return that justifies the structure.

Does the employer have a broker capable of managing the level funded relationship? Evaluating stop loss proposals, interpreting claims reports, managing the reconciliation process, and advising on plan design adjustments require expertise that not every broker has. An employer whose broker only places fully insured and has not managed a level funded group is poorly positioned to realize the product’s advantages. Broker capability is a prerequisite, not a given.

Does the employer have known high-cost members? A member receiving active cancer treatment, a member on maintenance biologic therapy for rheumatoid arthritis, or a member with hemophilia will surface in stop loss underwriting. The carrier will laser the individual, impose a higher specific deductible on their claims, or exclude the condition. If the employer’s highest-cost members are excluded from stop loss protection, level funded economics deteriorate significantly. Fully insured, where community rating prevents individual medical underwriting of covered employees, may be the better fit.

Price comparison establishes the minimum threshold. If level funded total cost exceeds fully insured renewal, the answer is clear for most employers. If level funded is cheaper, the question is whether the savings justify the complexity, the fiduciary responsibility, and the volatility. A 3 to 5 percent savings probably does not justify the added burden for a low-engagement employer. A 12 to 15 percent savings likely does for an employer with the capacity to realize the plan management benefits that compound the savings over time.

The Mistake to Avoid
#

The most common failure in this segment is choosing level funded on a single-year price comparison without understanding the multi-year dynamics. An employer who moves to level funded because it is 8 percent cheaper in year one, experiences a 30 percent renewal increase in year two after one catastrophic claim, and then returns to fully insured has not benefited from level funded. They experienced the downside without accumulating the surplus, data, and cost management improvements that make level funded financially superior over a three-to-five year horizon.

The broker’s role is to ensure the employer makes a structural choice grounded in their specific situation. The employer who understands the architecture, the tradeoffs, and the multi-year dynamics and chooses level funded on that basis is positioned to realize its full value. The employer who is sold level funded as simply cheaper without understanding the volatility and the engagement it requires will be disappointed.

How this article connects to others in Blue Gray Matters.

The stop loss experience-rating blend that begins shifting toward actual claims at 25 or more lives, reducing reliance on manual rates, is the underwriting counterpart to the employer data advantage this article describes; LFP-05.08 examines how the TPA assembles prior claims data for stop loss submission, and the credibility shift at this size changes both the premium calculation and the employer's negotiating position at renewal.
The chronic disease identification and management programs this article identifies as analytically feasible at 25 or more covered lives are the employer-side response to the chronic disease compounding problem LFP-09.09 analyzes, where multiple comorbidities in a small population generate claims significantly above demographic expectations.
The data advantage this article describes as compounding over time at this group size, enabling plan design adjustments year over year that reduce cost in ways the single-year fully insured comparison cannot capture, is the employer-facing rationale for the TPA cost management engine LFP-10.01 examines as the primary mechanism converting claims data into plan design action.
The pharmacy management lever this article identifies as accessible at 25 or more covered lives, including PBM negotiation, step therapy, and specialty drug prior authorization, is examined in depth in LFP-11.07, which analyzes how formulary design and PBM arrangement affect the pharmacy spend that represents 20 to 30 percent of total health care costs for most small group plans.
The employer profile this article describes, with HR capacity for plan engagement, enough scale for meaningful analytics, and appetite for custom plan design, maps to the Plus tier market; LFP-15.03 examines how the Plus tier is designed to serve this segment's administrative depth and plan management requirements.

Sources cited in this article.

  1. Kaiser Family Foundation. "Employer Health Benefits Survey 2025." KFF, Oct. 2025, www.kff.org/health-costs/2025-employer-health-benefits-survey/.
  2. Society for Human Resource Management. *Human Capital Benchmarking Report*. SHRM, 2024, www.shrm.org.
  3. Wager, Emma, et al. "Health Benefits in 2025: Family Premiums Rise 6 Percent." *Health Affairs*, Oct. 2025, doi.org/10.1377/hlthaff.2025.01106.